ARCT(Arcturus Therapeutics Holdings Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $12.36M | $206.00M | $166.80M | $152.31M | $82.03M |
| 毛利润 | — | — | — | — | — |
| 营业利润 | −$202.85M | $12.18M | −$78.20M | −$95.67M | −$76.26M |
| 净利润 | −$203.67M | $9.35M | −$29.73M | −$80.94M | −$65.78M |
| 经营现金流 | −$135.04M | $31.99M | −$18.10M | −$59.75M | −$74.27M |
| 自由现金流 | −$138.45M | $24.27M | −$21.00M | −$60.40M | −$74.50M |
| 摊薄每股收益 | $-7.74 | $0.35 | $-1.12 | $-3.00 | $-2.40 |